Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what criteria are used by the Clinical Priorities Advisory Group, the Specialised Commissioning Oversight Group and the Directly Commissioned Services Committee in their assessment of medicines for the treatment of rare diseases.
Answered by Earl Howe - Deputy Leader of the House of Lords
The membership by role of the Clinical Priorities Advisory Group (CPAG) and the Specialised Commissioning Oversight Group (SCOG) can be found in each group’s Terms of Reference which are published on NHS England’s website.
The criteria used by the CPAG and the SCOG can also be found in each group’s Terms of Reference. For those policies that require a commissioning decision in year then CPAG will use the In Year Service Development policy.
Copies of CPAGs Terms of Reference, SCOGs Terms of Reference and the In Year Service Development policy are attached.
The Directly Commissioned Services Committee has now ceased to exist. NHS England has advised that the first meetings of the new Commissioning Committee and the Specialised Commissioning Committee are expected in January. Membership of these committees has not yet been finalised.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether they will ask NHS England to publish the membership of its Clinical Priorities Advisory Group, its Specialised Commissioning Oversight Group and its Directly Commissioned Services Committee.
Answered by Earl Howe - Deputy Leader of the House of Lords
The membership by role of the Clinical Priorities Advisory Group (CPAG) and the Specialised Commissioning Oversight Group (SCOG) can be found in each group’s Terms of Reference which are published on NHS England’s website.
The criteria used by the CPAG and the SCOG can also be found in each group’s Terms of Reference. For those policies that require a commissioning decision in year then CPAG will use the In Year Service Development policy.
Copies of CPAGs Terms of Reference, SCOGs Terms of Reference and the In Year Service Development policy are attached.
The Directly Commissioned Services Committee has now ceased to exist. NHS England has advised that the first meetings of the new Commissioning Committee and the Specialised Commissioning Committee are expected in January. Membership of these committees has not yet been finalised.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government how many medicines for the treatment of rare diseases have been selected for assessment by the "Commissioning through Evaluation" mechanism.
Answered by Earl Howe - Deputy Leader of the House of Lords
The Commissioning through Evaluation programme was established by NHS England in 2013 as an innovative mechanism to capture further evaluative data to inform future clinical commissioning policy in areas that show significant promise, but with insufficient existing evidence of clinical and/or cost effectiveness to support routine National Health Service funding.
Five schemes are already in progress (selective internal radiation therapy, selective dorsal rhizotomy, Mitraclip, left atrial appendage occlusion and patent foramen ovale). These initial schemes all cover procedures, rather than drug treatments, at this stage.
NHS England will consider the potential for any further schemes as part of the wider resource prioritisation process in place.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what is their estimate of the value of unoccupied property and unused land owned by the National Health Service.
Answered by Earl Howe - Deputy Leader of the House of Lords
The information requested is not collected centrally.
National Health Service organisations are responsible locally for making decisions regarding the use of their facilities, including the use of property and land.